Source: European Journal of Pain. Unidade: FMRP
Subjects: BLOQUEADORES NEUROMUSCULARES, ANGIOTENSINA II, BRADICININA, GENÉTICA
ABNT
ZANATA, Graziele C. et al. Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice. European Journal of Pain, v. 25, n. 1, p. 189-198, 2021Tradução . . Disponível em: https://doi.org/10.1002/ejp.1660. Acesso em: 29 ago. 2024.APA
Zanata, G. C., Pinto, L. G., Silva, N. R. da, Lopes, A. H. P., Oliveira, F. F. B., Schivo, I. R. dos S., et al. (2021). Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice. European Journal of Pain, 25( 1), 189-198. doi:10.1002/ejp.1660NLM
Zanata GC, Pinto LG, Silva NR da, Lopes AHP, Oliveira FFB, Schivo IR dos S, Cunha F de Q, McNaughton P, Cunha TM, Silva RL. Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice [Internet]. European Journal of Pain. 2021 ; 25( 1): 189-198.[citado 2024 ago. 29 ] Available from: https://doi.org/10.1002/ejp.1660Vancouver
Zanata GC, Pinto LG, Silva NR da, Lopes AHP, Oliveira FFB, Schivo IR dos S, Cunha F de Q, McNaughton P, Cunha TM, Silva RL. Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel‐associated acute pain syndrome in mice [Internet]. European Journal of Pain. 2021 ; 25( 1): 189-198.[citado 2024 ago. 29 ] Available from: https://doi.org/10.1002/ejp.1660